December

December 7, 2017

Natural product-based therapy for Deafness: a therapeutic mix encompassing Venlafaxine, Cholecalciferol, Ajoene and DIM (VCAD)  increases the expression of ATG5 (Autophagy-related 5), prevents aggregation of proteins in inclusion bodies, inhibits hair cell degeneration,  improves hearing loss via up regulation of its target genes, 7/December/2017, 8.33 am

What we say: Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Natural product-based therapy for Deafness: a therapeutic mix encompassing Venlafaxine, Cholecalciferol, Ajoene and DIM (VCAD)  increases the […]
December 7, 2017

Molecular therapy for TIIDM and obesity-associated metabolic deficits: N-Acetyl Serotonin increases Lipocalin 2 (LCN2) expression, activates an MC4R-dependent anorexigenic pathway, suppresses appetite and weight gain, increases insulin secretion, improves glucose tolerance, promotes glucose homeostasis, improves obesity-associated metabolic deficits and prevents progression to TIIDM via down regulation of its target gene, 7/December/2017, 7.13 am

Introduction: What they say A study from the Department of Physiology-Cellular Biophysics, College of Physicians and Surgeons, Columbia University, New York, New York, USA shows that […]
December 7, 2017

Natural product therapy for body weight control, energy homeostasis and TIIDM:  Huperzine A decreases CADM1 and its downstream target genes that promote glucose-induced insulin secretion, improves insulin sensitivity, increases energy utilization, promotes weight loss and protects from diet-induced obesity and TIIDM via up regulation of its target gene, 7/December/2017, 6.18 am

Introduction: What they say A study from the Max Delbrück Center for Molecular Medicine, Berlin, Germany shows that “Regulation of body weight and energy homeostasis by […]
December 5, 2017

Molecular therapy for body weight control, energy homeostasis and TIIDM: Rosiglitazone(Brand name: Avantia), an anti-hyperglycemic medication,  inhibits DNA methyltransferase 3a (Dnmt3a) expression, increases FGF21 expression, augments insulin sensitivity, increases glucose tolerance, and protects from diet-induced obesity and TIIDM, via up regulation of its target gene, 6/December/2017, 12.24 am

Introduction: What they say A study from Nutritional Sciences and Toxicology Department, University of California, Berkeley, Berkeley, United States shows that “Dnmt3a is an epigenetic mediator […]